Skip to main content
. 2014 Mar 6;25(6):1357–1366. doi: 10.1681/ASN.2013040430

Figure 6.

Figure 6.

Time to achievement of remission of proteinuria in patients with high versus low PLA2R antibody levels at study inclusion. (A) Mean and median time to remission of proteinuria. The 128 patients for whom ELISA PLA2R antibody levels are available are divided in two groups. In patients in the low group, PLA2R antibody levels at study inclusion are lower than the median PLA2R antibody level. In patients in the high group, PLA2R antibody levels at study inclusion are higher than the median PLA2R antibody levels. For five patients, there are no ELISA PLA2R antibody levels available at the time of study inclusion and they are not included in this analysis. (B) Kaplan–Meier analysis. Patients with low PLA2R antibody levels at study inclusion (low group) reach remission of proteinuria significantly faster than patients with high PLA2R antibody levels at study inclusion (high group). N gives the number of patients at the different time points.